80 related articles for article (PubMed ID: 8719029)
1. Is there a relationship between baseline and treatment-associated changes in [3H]-IMI platelet binding and clinical response in major depression?
Tollefson GD; Heiligenstein JH; Tollefson SL; Birkett MA; Knight DL; Nemeroff CB
Neuropsychopharmacology; 1996 Jan; 14(1):47-53. PubMed ID: 8719029
[TBL] [Abstract][Full Text] [Related]
2. Is baseline agitation a relative contraindication for a selective serotonin reuptake inhibitor: a comparative trial of fluoxetine versus imipramine.
Tollefson GD; Greist JH; Jefferson JW; Heiligenstein JH; Sayler ME; Tollefson SL; Koback K
J Clin Psychopharmacol; 1994 Dec; 14(6):385-91. PubMed ID: 7884018
[TBL] [Abstract][Full Text] [Related]
3. Imipramine binding as a predictor of fluoxetine response in depressed patients.
Castrogiovanni P; Di Muro A; Marazziti D
Neuropsychobiology; 1995; 31(2):64-7. PubMed ID: 7760987
[TBL] [Abstract][Full Text] [Related]
4. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
[TBL] [Abstract][Full Text] [Related]
5. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder.
Wgner A; Montero D; Mårtensson B; Siwers B; Asberg M
J Affect Disord; 1990 Oct; 20(2):101-13. PubMed ID: 2176228
[TBL] [Abstract][Full Text] [Related]
6. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
[TBL] [Abstract][Full Text] [Related]
7. [The effect of imipramine and trazodone on the re-uptake of (3H) serotonin by thrombocytes in patients with endogenous depression: changes in antidepressive therapy].
Katasonow AB; Brusow OS; Beljaew BS; Slobina GP; Faktor MI; Larionowa TB; Trunte K; Lidemann RR
Psychiatr Neurol Med Psychol (Leipz); 1989 Apr; 41(4):210-7. PubMed ID: 2544916
[TBL] [Abstract][Full Text] [Related]
8. Allosteric interaction between the site labeled by [3H]imipramine and the serotonin transporter in human platelets.
Meyerson LR; Ieni JR; Wennogle LP
J Neurochem; 1987 Feb; 48(2):560-5. PubMed ID: 3491878
[TBL] [Abstract][Full Text] [Related]
9. A double-blind study of fluoxetine and imipramine in major depression.
Bressa GM; Brugnoli R; Pancheri P
Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():69-73. PubMed ID: 2783701
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic markers in platelets of patients with major depression: upregulation of 5-HT2 receptors.
Hrdina PD; Bakish D; Chudzik J; Ravindran A; Lapierre YD
J Psychiatry Neurosci; 1995 Jan; 20(1):11-9. PubMed ID: 7865496
[TBL] [Abstract][Full Text] [Related]
11. [Sensitivity of the retrograde uptake of H3-serotonin to imipramine and trazodone in patients with endogenous depression treated with antidepressive drugs].
Katasonov AB; Beliaev BS; Zlobina GP; Faktor MI; Brusov OS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(2):125-8. PubMed ID: 2728713
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine, a selective serotonin uptake inhibitor, for the treatment of outpatients with major depression.
Byerley WF; Reimherr FW; Wood DR; Grosser BI
J Clin Psychopharmacol; 1988 Apr; 8(2):112-5. PubMed ID: 3286684
[TBL] [Abstract][Full Text] [Related]
13. Influence of age, sex and diurnal variability on imipramine receptor binding and serotonin uptake in platelets of normal subjects.
Halbreich U; Rojansky N; Zander KJ; Barkai A
J Psychiatr Res; 1991; 25(1-2):7-18. PubMed ID: 1851224
[TBL] [Abstract][Full Text] [Related]
14. High-dose fluoxetine: efficacy and activating-sedating effects in agitated and retarded depression.
Beasley CM; Sayler ME; Bosomworth JC; Wernicke JF
J Clin Psychopharmacol; 1991 Jun; 11(3):166-74. PubMed ID: 2066455
[TBL] [Abstract][Full Text] [Related]
15. Imipramine binding in platelets of patients with panic disorder.
Marazziti D; Rotondo A; Placidi GF; Perugi G; Cassano GB; Pacifici GM
Pharmacopsychiatry; 1988 Jan; 21(1):47-9. PubMed ID: 3362963
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine in depressed patients: a comparison with imipramine.
Bremner JD
J Clin Psychiatry; 1984 Oct; 45(10):414-9. PubMed ID: 6384203
[TBL] [Abstract][Full Text] [Related]
17. Platelet 3H-imipramine binding sites in obsessive-compulsive behavior.
Kim SW; Dysken MW; Pandey GN; Davis JM
Biol Psychiatry; 1991 Sep; 30(5):467-74. PubMed ID: 1657222
[TBL] [Abstract][Full Text] [Related]
18. Fluoxetine compared with imipramine in the treatment of inpatient depression. A multicenter trial.
Beasley CM; Holman SL; Potvin JH
Ann Clin Psychiatry; 1993 Sep; 5(3):199-207. PubMed ID: 8281243
[TBL] [Abstract][Full Text] [Related]
19. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Cohn JB; Wilcox C
J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
[TBL] [Abstract][Full Text] [Related]
20. High- and low-affinity [3H]imipramine binding sites on human platelets: separate determination and involvement of sulphur-containing bonds.
Demushkin VP; Fomenko AM; Plyashkevich YG; Shchurin MR; Brusov OS
Eur J Pharmacol; 1987 Aug; 140(2):171-8. PubMed ID: 2822438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
